Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022237067> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2022237067 endingPage "1371" @default.
- W2022237067 startingPage "1364" @default.
- W2022237067 abstract "Mammalian ribonucleotide reductase, which occupies a key position in the synthesis of DNA, is a highly controlled enzyme activity, because it is solely responsible for the de novo reduction of ribonucleoside diphosphates to their corresponding deoxyribonucleoside diphosphate forms, required for DNA synthesis. Ribonucleotide reductase consists of two dissimilar protein components often called M1 and M2, which are independently regulated during cell proliferation. The M1 component contains multiple effector binding sites and is responsible for the complex allosteric regulation of the enzyme, whereas the M2 protein contains nonheme iron and a unique tyrosyl-free radical required for ribonucleotide reduction. Since the reaction is rate limiting for DNA synthesis, ribonucleotide reductase plays an important role in regulating cell division, and hence, cell proliferation. There are many inhibitors of ribonucleotide reductase and perhaps the most valuable one from a cell biology, biochemistry, and clinical point of view is the hydroxamic acid, hydroxyurea. This drug has also been very useful as a selective agent for isolating a variety of mammalian mutant cell lines altered in ribonucleotide reductase gene expression. Regulatory, structural, and biological characteristics of ribonucleotide reductase are reviewed, including evidence that ribonucleotide reductase, particularly the M2 protein, has an important early role to play in tumor promotion. In addition, modifications in the expressions of genes altered in hydroxyurea-resistant mutants and cultured in the absence or presence of hydroxyurea are discussed, with emphasis on changes in M2 protein, M1 protein, and the iron-storage protein ferritin.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2022237067 created "2016-06-24" @default.
- W2022237067 creator A5011113511 @default.
- W2022237067 creator A5016662979 @default.
- W2022237067 creator A5032047953 @default.
- W2022237067 creator A5060124599 @default.
- W2022237067 creator A5067049945 @default.
- W2022237067 creator A5070483557 @default.
- W2022237067 date "1990-12-01" @default.
- W2022237067 modified "2023-10-16" @default.
- W2022237067 title "Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis" @default.
- W2022237067 doi "https://doi.org/10.1139/o90-199" @default.
- W2022237067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2085432" @default.
- W2022237067 hasPublicationYear "1990" @default.
- W2022237067 type Work @default.
- W2022237067 sameAs 2022237067 @default.
- W2022237067 citedByCount "87" @default.
- W2022237067 countsByYear W20222370672012 @default.
- W2022237067 countsByYear W20222370672013 @default.
- W2022237067 countsByYear W20222370672014 @default.
- W2022237067 countsByYear W20222370672015 @default.
- W2022237067 countsByYear W20222370672018 @default.
- W2022237067 countsByYear W20222370672019 @default.
- W2022237067 countsByYear W20222370672021 @default.
- W2022237067 crossrefType "journal-article" @default.
- W2022237067 hasAuthorship W2022237067A5011113511 @default.
- W2022237067 hasAuthorship W2022237067A5016662979 @default.
- W2022237067 hasAuthorship W2022237067A5032047953 @default.
- W2022237067 hasAuthorship W2022237067A5060124599 @default.
- W2022237067 hasAuthorship W2022237067A5067049945 @default.
- W2022237067 hasAuthorship W2022237067A5070483557 @default.
- W2022237067 hasConcept C104292427 @default.
- W2022237067 hasConcept C104317684 @default.
- W2022237067 hasConcept C104788683 @default.
- W2022237067 hasConcept C134651460 @default.
- W2022237067 hasConcept C181199279 @default.
- W2022237067 hasConcept C4710235 @default.
- W2022237067 hasConcept C512185932 @default.
- W2022237067 hasConcept C552990157 @default.
- W2022237067 hasConcept C55493867 @default.
- W2022237067 hasConcept C64241487 @default.
- W2022237067 hasConcept C86803240 @default.
- W2022237067 hasConcept C98892162 @default.
- W2022237067 hasConceptScore W2022237067C104292427 @default.
- W2022237067 hasConceptScore W2022237067C104317684 @default.
- W2022237067 hasConceptScore W2022237067C104788683 @default.
- W2022237067 hasConceptScore W2022237067C134651460 @default.
- W2022237067 hasConceptScore W2022237067C181199279 @default.
- W2022237067 hasConceptScore W2022237067C4710235 @default.
- W2022237067 hasConceptScore W2022237067C512185932 @default.
- W2022237067 hasConceptScore W2022237067C552990157 @default.
- W2022237067 hasConceptScore W2022237067C55493867 @default.
- W2022237067 hasConceptScore W2022237067C64241487 @default.
- W2022237067 hasConceptScore W2022237067C86803240 @default.
- W2022237067 hasConceptScore W2022237067C98892162 @default.
- W2022237067 hasIssue "12" @default.
- W2022237067 hasLocation W20222370671 @default.
- W2022237067 hasLocation W20222370672 @default.
- W2022237067 hasOpenAccess W2022237067 @default.
- W2022237067 hasPrimaryLocation W20222370671 @default.
- W2022237067 hasRelatedWork W1580974913 @default.
- W2022237067 hasRelatedWork W1986778880 @default.
- W2022237067 hasRelatedWork W1991737003 @default.
- W2022237067 hasRelatedWork W2006000374 @default.
- W2022237067 hasRelatedWork W2016936486 @default.
- W2022237067 hasRelatedWork W2022237067 @default.
- W2022237067 hasRelatedWork W2065911028 @default.
- W2022237067 hasRelatedWork W2075241044 @default.
- W2022237067 hasRelatedWork W2083419573 @default.
- W2022237067 hasRelatedWork W2411913712 @default.
- W2022237067 hasVolume "68" @default.
- W2022237067 isParatext "false" @default.
- W2022237067 isRetracted "false" @default.
- W2022237067 magId "2022237067" @default.
- W2022237067 workType "article" @default.